Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""DRUG therapy"" wg kryterium: Temat


Tytuł :
Usefulness of β-lactam and macrolide combination therapy for treating community-acquired pneumonia patients hospitalized in the intensive care unit: Propensity score analysis of a prospective cohort study.
Autorzy :
Ito A; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan. Electronic address: .
Ishida T; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan. Electronic address: .
Tachibana H; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan; Department of Respiratory Medicine, National Hospital Organization Minami Kyoto Hospital, 11 Nakaashihara, Joyo, Kyoto 610-0113, Japan. Electronic address: .
Nakanishi Y; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan. Electronic address: .
Tokioka F; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan. Electronic address: .
Yamazaki A; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan; Department of Respiratory Medicine, Shiga University of Medical Science, Tsukinowa Seta-cho, Otsu, Shiga 520-2192, Japan. Electronic address: .
Washio Y; Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan; Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Higashiku, Maidashi, Fukuoka 812-8582, Japan. Electronic address: .
Irie H; Department of Anesthesia, Ohara Healthcare Foundation, Kurashiki Central Hospital, 1-1-1 Miwa, Kurashiki, Okayama 710-8602, Japan. Electronic address: .
Otake T; Department of Intensive Care, Ohara Healthcare Foundation, Kurashiki Central Hospital, Kurashiki, Okayama 710-8602, Japan. Electronic address: .
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Oct; Vol. 27 (10), pp. 1447-1453. Date of Electronic Publication: 2021 Jun 17.
Typ publikacji :
Journal Article
MeSH Terms :
Community-Acquired Infections*/drug therapy
Pneumonia, Bacterial*/drug therapy
Anti-Bacterial Agents/therapeutic use ; Cohort Studies ; Drug Therapy, Combination ; Humans ; Intensive Care Units ; Macrolides/therapeutic use ; Propensity Score ; Prospective Studies ; Treatment Outcome ; beta-Lactams/therapeutic use
Czasopismo naukowe
Tytuł :
Effect of sofosbuvir-based DAAs on changes in lower-density lipoprotein in HCV patients: a systematic review and meta-analysis.
Autorzy :
Wang YW; Healthcare and Management Center, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Lee WP; Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.; Institute of Biochemistry and Molecular Biology, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Huang YH; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201, Section 2, Shi-Pai Road, Taipei, 112, Taiwan, ROC.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.; Institute of Clinical Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Hou MC; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201, Section 2, Shi-Pai Road, Taipei, 112, Taiwan, ROC.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Lan KH; Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, 201, Section 2, Shi-Pai Road, Taipei, 112, Taiwan, ROC. .; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC. .; Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2021 Sep 21; Vol. 21 (1), pp. 984. Date of Electronic Publication: 2021 Sep 21.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; Drug Therapy, Combination ; Genotype ; Hepacivirus ; Humans ; Lipoproteins, LDL ; Ribavirin/therapeutic use ; Sofosbuvir/therapeutic use ; Sustained Virologic Response ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Completion Rate and Safety of Programmatic Screening and Treatment for Latent Tuberculosis Infection in Elderly Patients With Poorly Controlled Diabetic Mellitus: A Prospective Multicenter Study.
Autorzy :
Huang HL; Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang WC; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan.; Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung, Taiwan.; Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Lin KD; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Liu SS; Nursing Department, Taichung Veterans General Hospital, Taichung, Taiwan.
Lee MR; Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; National Taiwan University, College of Medicine, Taipei, Taiwan.
Cheng MH; Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chin CS; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Lu PL; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Center for Liquid Biopsy and Cohort Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Sheu CC; Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Wang JY; Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.; National Taiwan University, College of Medicine, Taipei, Taiwan.
Lee IT; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; School of Medicine, National Yang-Ming University, Taiwan.; College of Science, Tunghai University, Taiwan.
Chong IW; Division of Pulmonary and Critical Care Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Respiratory Therapy, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Adjunct Professor, Department of Biological Science and Technology National Chiao Tung University, Taiwan.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Sep 15; Vol. 73 (6), pp. e1252-e1260.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus*/drug therapy
Latent Tuberculosis*/complications
Latent Tuberculosis*/diagnosis
Latent Tuberculosis*/drug therapy
Aged ; Antitubercular Agents ; Drug Therapy, Combination ; Humans ; Isoniazid/therapeutic use ; Middle Aged ; Prospective Studies
Czasopismo naukowe
Tytuł :
Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting.
Autorzy :
Yuen CM; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School Center for Global Health Delivery, Boston, Massachusetts, USA.
Majidulla A; Interactive Research and Development, Karachi, Pakistan.
Jaswal M; Global Health Directorate, Indus Health Network, Karachi, Pakistan.
Safdar N; Global Health Directorate, Indus Health Network, Karachi, Pakistan.
Malik AA; Global Health Directorate, Indus Health Network, Karachi, Pakistan.; Interactive Research and Development (IRD) Global, Singapore.
Khan AJ; Harvard Medical School Center for Global Health Delivery, Boston, Massachusetts, USA.; Interactive Research and Development (IRD) Global, Singapore.
Becerra MC; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School Center for Global Health Delivery, Boston, Massachusetts, USA.
Keshavjee S; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School Center for Global Health Delivery, Boston, Massachusetts, USA.
Lu C; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Hussain H; Interactive Research and Development (IRD) Global, Singapore.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Sep 07; Vol. 73 (5), pp. e1135-e1141.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Latent Tuberculosis*/drug therapy
Latent Tuberculosis*/prevention & control
Tuberculosis*/drug therapy
Tuberculosis*/prevention & control
Antitubercular Agents/therapeutic use ; Cost-Benefit Analysis ; Drug Therapy, Combination ; Humans ; Isoniazid/therapeutic use ; Rifampin/analogs & derivatives
Czasopismo naukowe
Tytuł :
Treatment-Resistant Depression: Approaches to Treatment.
Autorzy :
Kverno KS
Mangano E
Pokaż więcej
Źródło :
Journal of psychosocial nursing and mental health services [J Psychosoc Nurs Ment Health Serv] 2021 Sep; Vol. 59 (9), pp. 7-11. Date of Electronic Publication: 2021 Sep 01.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Depressive Disorder, Major*/drug therapy
Depressive Disorder, Treatment-Resistant*/drug therapy
Antidepressive Agents/therapeutic use ; Depression ; Drug Therapy, Combination ; Humans
Czasopismo naukowe
Tytuł :
Profiling the physiological pitfalls of anti-hepatitis C direct-acting agents in budding yeast.
Autorzy :
Yahya G; Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Al Sharqia, 44519, Egypt.; Department of Molecular Genetics, Faculty of Biology, Technical University of Kaiserslautern, Paul-Ehrlich Str. 24, Kaiserslautern, 67663, Germany.
Hashem Mohamed N; Hospitals of Zagazig University, Al Sharqia, Egypt.
Pijuan J; Laboratory of Neurogenetics and Molecular Medicine - IPER, Institut de Recerca Sant Joan de Déu, Barcelona, 08950, Spain.
Seleem NM; Department of Microbiology and Immunology, Faculty of Pharmacy, Zagazig University, Al Sharqia, 44519, Egypt.
Mosbah R; Infection Control Unit, Hospitals of Zagazig University, Al Sharqia, Egypt.
Hess S; Department of Cell Biology, Faculty of Biology, Technical University of Kaiserslautern, Kaiserslautern, Germany.
Abdelmoaty AA; Department of Tropical Medicine, Faculty of Medicine, Zagazig University, Zagazig, 44519, Egypt.
Almeer R; Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
Abdel-Daim MM; Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.; Pharmacology Department, College of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.
Shulaywih Alshaman H; Department of Urology, King Salman armed forces hospital, Tabuk, Saudi Arabia.
Juraiby I; General Directorate of Health Affairs, Ministry of Health, Jazan, 82723, Saudi Arabia.
Metwally K; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tabuk University, Tabuk, 47713, Saudi Arabia.; Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt.
Storchova Z; Department of Molecular Genetics, Faculty of Biology, Technical University of Kaiserslautern, Paul-Ehrlich Str. 24, Kaiserslautern, 67663, Germany.
Pokaż więcej
Źródło :
Microbial biotechnology [Microb Biotechnol] 2021 Sep; Vol. 14 (5), pp. 2199-2213. Date of Electronic Publication: 2021 Aug 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Saccharomycetales*
Antiviral Agents/adverse effects ; Drug Therapy, Combination ; Hepacivirus/genetics ; Humans
Czasopismo naukowe
Tytuł :
Real world SOF/VEL/VOX retreatment outcomes and viral resistance analysis for HCV patients with prior failure to DAA therapy.
Autorzy :
Smith DA; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Bradshaw D; National Infection Service, Public Health England, London, UK.
Mbisa JL; National Infection Service, Public Health England, London, UK.
Manso CF; National Infection Service, Public Health England, London, UK.
Bibby DF; National Infection Service, Public Health England, London, UK.
Singer JB; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Thomson EC; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
da Silva Filipe A; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Aranday-Cortes E; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Ansari MA; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Brown A; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Hudson E; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Benselin J; NIHR Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
Healy B; Public Health Wales Microbiology Cardiff, University Hospital of Wales, Cardiff, UK.
Troke P; Gilead Sciences Ltd, London, UK.
McLauchlan J; MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
Barnes E; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.; NIHR Oxford Biomedical Research Centre, Oxford, UK.
Irving WL; NIHR Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło :
Journal of viral hepatitis [J Viral Hepat] 2021 Sep; Vol. 28 (9), pp. 1256-1264. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma, Hepatocellular*/drug therapy
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Liver Neoplasms*/drug therapy
Antiviral Agents/therapeutic use ; Drug Therapy, Combination ; Genotype ; Hepacivirus/genetics ; Humans ; Retreatment ; Sofosbuvir/therapeutic use ; Sustained Virologic Response
Czasopismo naukowe
Tytuł :
Dabigatran-based dual antithrombotic therapy for patients with atrial fibrillation and ST-elevation myocardial infarction undergoing percutaneous coronary intervention.
Autorzy :
Angiolillo DJ; Division of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA.
Galli M
Pokaż więcej
Źródło :
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2021 Aug 27; Vol. 17 (6), pp. 443-444.
Typ publikacji :
Journal Article
MeSH Terms :
Atrial Fibrillation*/complications
Atrial Fibrillation*/drug therapy
Percutaneous Coronary Intervention*/adverse effects
ST Elevation Myocardial Infarction*/drug therapy
Anticoagulants/adverse effects ; Dabigatran/adverse effects ; Drug Therapy, Combination ; Fibrinolytic Agents/adverse effects ; Humans ; Platelet Aggregation Inhibitors/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Dual antithrombotic therapy with dabigatran in patients with atrial fibrillation after percutaneous coronary intervention for ST-segment elevation myocardial infarction: a post hoc analysis of the randomised RE-DUAL PCI trial.
Autorzy :
Zeymer U; Klinikum Ludwigshafen and Institut für Herzinfarktforschung, Ludwigshafen, Germany.
Leiva O
Hohnloser SH
Steg PG
Oldgren J
Nickenig G
Gabor Kiss R
Ongen Z
Navarro Estrada J
Oude Ophuis T
Lip GYH
Nordaby M
Miede C
Ten Berg JM
Bhatt DL
Cannon CP
Pokaż więcej
Źródło :
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2021 Aug 27; Vol. 17 (6), pp. 474-480.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Atrial Fibrillation*/complications
Atrial Fibrillation*/drug therapy
Coronary Artery Disease*/drug therapy
Percutaneous Coronary Intervention*/adverse effects
ST Elevation Myocardial Infarction*/drug therapy
Anticoagulants/adverse effects ; Aspirin/therapeutic use ; Dabigatran/adverse effects ; Drug Therapy, Combination ; Fibrinolytic Agents/therapeutic use ; Humans ; Platelet Aggregation Inhibitors/adverse effects
Czasopismo naukowe
Tytuł :
A Clinical Update on Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke.
Autorzy :
Marsden K; Department of Neurology, University of Washington, Seattle, SA, USA. .
Mak HY; Department of Pharmacy, University of Washington, Seattle, SA, USA.
Crooks CP; Department of Neurology, University of Washington, Seattle, SA, USA.
Pankaj P; Department of Neurology, University of Washington, Seattle, SA, USA.
Nguyen T; Department of Neurology, University of Washington, Seattle, SA, USA.
Tirschwell D; Department of Neurology, University of Washington, Seattle, SA, USA.
Pokaż więcej
Źródło :
Current cardiology reports [Curr Cardiol Rep] 2021 Aug 19; Vol. 23 (10), pp. 145. Date of Electronic Publication: 2021 Aug 19.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Brain Ischemia*/drug therapy
Brain Ischemia*/prevention & control
Ischemic Attack, Transient*/drug therapy
Ischemic Stroke*
Stroke*/drug therapy
Stroke*/prevention & control
Drug Therapy, Combination ; Humans ; Platelet Aggregation Inhibitors/therapeutic use ; Secondary Prevention
Czasopismo naukowe
Tytuł :
Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection.
Autorzy :
Kendall MA; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Lalloo U; Enhancing Care Foundation, Durban International Clinical Research Site (CRS), Durban, South Africa.
Fletcher CV; UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Wu X; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Podany AT; UNMC Center for Drug Discovery, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Cardoso SW; Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS, Rio de Janeiro, Brazil.
Ive P; Clinical HIV Research Unit, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Benson CA; Antiviral Research Center, University of California, San Diego, San Diego, California, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Aug 16; Vol. 73 (4), pp. 706-715.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-HIV Agents*/adverse effects
Coinfection*/drug therapy
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Protease Inhibitors*/adverse effects
Tuberculosis*/complications
Tuberculosis*/drug therapy
Adult ; Drug Therapy, Combination ; Female ; HIV ; Humans ; Lopinavir/therapeutic use ; Male ; Rifabutin/therapeutic use ; Rifampin/therapeutic use ; Ritonavir/therapeutic use
Czasopismo naukowe
Tytuł :
Increased risk of short-term depressive disorder after Helicobacter pylori eradication: A population-based nested cohort study.
Autorzy :
Tsai CF; Institute of Brain Science, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.
Chen MH; Institute of Brain Science, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.
Wang YP; Institute of Brain Science, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.; Endoscopy Center for Diagnosis and Treatment, Taipei Veterans General Hospital, Taipei, Taiwan.; Division of Gastroenteorlogy, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Liu PY; Institute of Brain Science, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.; Endoscopy Center for Diagnosis and Treatment, Taipei Veterans General Hospital, Taipei, Taiwan.
Hou MC; Institute of Brain Science, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.; Endoscopy Center for Diagnosis and Treatment, Taipei Veterans General Hospital, Taipei, Taiwan.; Division of Gastroenteorlogy, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Lee FY; Institute of Brain Science, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.; Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan.; Division of Gastroenteorlogy, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Lu CL; Institute of Brain Science, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.; Faculty of Medicine, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan.; Endoscopy Center for Diagnosis and Treatment, Taipei Veterans General Hospital, Taipei, Taiwan.; Division of Gastroenteorlogy, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Helicobacter [Helicobacter] 2021 Aug; Vol. 26 (4), pp. e12824. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article
MeSH Terms :
Depressive Disorder*/drug therapy
Helicobacter Infections*/complications
Helicobacter Infections*/drug therapy
Helicobacter Infections*/epidemiology
Helicobacter pylori*
Anti-Bacterial Agents/therapeutic use ; Anti-Ulcer Agents/therapeutic use ; Cohort Studies ; Drug Therapy, Combination ; Female ; Humans ; Male ; Taiwan/epidemiology
Czasopismo naukowe
Tytuł :
Second direct-acting antiviral therapy for hepatitis C virus infection after umbilical cord blood transplantation: A case report.
Autorzy :
Onodera K; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan. Electronic address: .
Onishi Y; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Inoue J; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Tanaka Y; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yonha L; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ichikawa S; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Fukuhara N; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yokoyama H; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Murai K; Department of Hematology, Iwate Prefectural Central Hospital, Iwate, Japan.
Masamune A; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Harigae H; Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Aug; Vol. 27 (8), pp. 1230-1233. Date of Electronic Publication: 2021 Feb 12.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Cord Blood Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/adverse effects
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; Drug Therapy, Combination ; Hepacivirus/genetics ; Humans
Czasopismo naukowe
Tytuł :
Single-pill sofosbuvir and daclatasvir for treating hepatis C in patients co-infected with human immunodeficiency virus.
Autorzy :
Dehghan Manshadi SA; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
Merat S; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohraz M; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
Rasoolinejad M; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
Sali S; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mardani M; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tabarsi P; Clinical Tuberculosis and Epidemiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Somi MH; Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Sedghi R; Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Tayeri K; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
Nikbin M; Iranian Charity for Patients with Liver Disease, Tehran, Iran.
Karimi J; Department of Infectious Diseases and Tropical Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Sharifi AH; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Kalantari S; Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran.
Norouzi A; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Science, Gorgan, Iran.
Merat D; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Malekzadeh Z; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mirminachi B; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Poustchi H; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Malekzadeh R; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło :
International journal of clinical practice [Int J Clin Pract] 2021 Aug; Vol. 75 (8), pp. e14304. Date of Electronic Publication: 2021 May 17.
Typ publikacji :
Journal Article
MeSH Terms :
Coinfection*/drug therapy
HIV Infections*/complications
HIV Infections*/drug therapy
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; Carbamates ; Drug Therapy, Combination ; Genotype ; HIV ; Humans ; Imidazoles ; Pyrrolidines ; Ribavirin/therapeutic use ; Sofosbuvir/therapeutic use ; Treatment Outcome ; Valine/analogs & derivatives
Czasopismo naukowe
Tytuł :
Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients.
Autorzy :
Guo WF; Key Laboratory of Information Fusion Technology of Ministry of Education, School of Automation, Northwestern Polytechnical University, Xian 710072, China.; School of Electrical Engineering, Zhengzhou University, Zhengzhou 450001, China.
Zhang SW; Key Laboratory of Information Fusion Technology of Ministry of Education, School of Automation, Northwestern Polytechnical University, Xian 710072, China.
Feng YH; Key Laboratory of Information Fusion Technology of Ministry of Education, School of Automation, Northwestern Polytechnical University, Xian 710072, China.
Liang J; School of Electrical Engineering, Zhengzhou University, Zhengzhou 450001, China.
Zeng T; CAS Key Laboratory of Computational Biology, Bio-Med Big Data Center, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.; Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy Science, Shanghai 200031, China.
Chen L; Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy Science, Shanghai 200031, China.; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.; Center for Excellence in Animal Evolution and Genetics, Chinese Academy of Sciences, Kunming 650223, China.; Key Laboratory of Systems Biology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Hangzhou 310024, China.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2021 Apr 19; Vol. 49 (7), pp. e37.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Algorithms*
Drug Therapy, Combination*
Breast Neoplasms/*drug therapy
Breast Neoplasms/*genetics
Lung Neoplasms/*drug therapy
Lung Neoplasms/*genetics
Precision Medicine/*methods
Breast Neoplasms/classification ; COVID-19/drug therapy ; COVID-19/genetics ; Datasets as Topic ; Drug Repositioning ; Drug Synergism ; Drug-Related Side Effects and Adverse Reactions ; Gene Expression Regulation, Neoplastic/genetics ; Genes, Neoplasm/genetics ; Humans ; Risk Assessment ; Workflow
Czasopismo naukowe
Tytuł :
Treatment of chemotherapy-induced cachexia with BST204: a multimodal validation study.
Autorzy :
Kim HJ; Department of Medical Science, Asan Medical Center, Asan Medical Institute of Convergence and Technology, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Kim SJ; Department of Convergence Medicine, Asan Medical Center, Asan Medical Institute of Convergence and Technology, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Woo CW; MR Core Laboratory, Asan Medical Center, Asan Medical Institute of Convergence and Technology,, Seoul, Republic of Korea.
Kim ST; MR Core Laboratory, Asan Medical Center, Asan Medical Institute of Convergence and Technology,, Seoul, Republic of Korea.
Im M; GREEN CROSS Wellbeing Co., Ltd, Seongnam, Republic of Korea.
Park SK; GREEN CROSS Wellbeing Co., Ltd, Seongnam, Republic of Korea.
Kim JY; GREEN CROSS Wellbeing Co., Ltd, Seongnam, Republic of Korea.
Yoo HJ; Department of Convergence Medicine, Asan Medical Center, Asan Medical Institute of Convergence and Technology, University of Ulsan College of Medicine, Seoul, Republic of Korea. .
Woo DC; Department of Convergence Medicine, Asan Medical Center, Asan Medical Institute of Convergence and Technology, University of Ulsan College of Medicine, Seoul, Republic of Korea. .; MR Core Laboratory, Asan Medical Center, Asan Medical Institute of Convergence and Technology,, Seoul, Republic of Korea. .
Kim JK; Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. .
Pokaż więcej
Źródło :
Metabolomics : Official journal of the Metabolomic Society [Metabolomics] 2021 Mar 18; Vol. 17 (4), pp. 36. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Drug Therapy*
Drug-Related Side Effects and Adverse Reactions*
Cachexia/*chemically induced
Cachexia/*drug therapy
Plant Extracts/*pharmacology
Animals ; Cell Line, Tumor ; Colonic Neoplasms/drug therapy ; Colonic Neoplasms/pathology ; Disease Models, Animal ; Glucose/metabolism ; Inflammation ; Interleukin-6/blood ; Male ; Metabolomics ; Mice ; Mice, Inbred BALB C ; Oxidative Stress
Czasopismo naukowe
Tytuł :
Randomized trial of high-dose pyridoxine in combination with standard hormonal therapy in West syndrome.
Autorzy :
Banerjee A; Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sahu JK; Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Electronic address: .
Sankhyan N; Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pattanaik S; Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Suthar R; Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Saini AG; Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Saini L; Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Negi S; Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Malhi P; Child Psychology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Singhi P; Pediatric Neurology Unit, Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pokaż więcej
Źródło :
Seizure [Seizure] 2021 Oct; Vol. 91, pp. 75-80. Date of Electronic Publication: 2021 May 29.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Pyridoxine*/therapeutic use
Spasms, Infantile*/drug therapy
Administration, Oral ; Adrenocorticotropic Hormone/therapeutic use ; Drug Therapy, Combination ; Humans ; Infant
Czasopismo naukowe
Tytuł :
Vasoplegic syndrome after cardiovascular surgery: A review of pathophysiology and outcome-oriented therapeutic management.
Autorzy :
Datt V; Department of Cardiac Anaesthesia and Cardiothoracic and Vascular Surgery, GB Pant Hospital [GIPMER], New Delhi, India.
Wadhhwa R; Department of Cardiac Anaesthesia and Cardiothoracic and Vascular Surgery, GB Pant Hospital [GIPMER], New Delhi, India.
Sharma V; Department of Cardiac Anaesthesia and Cardiothoracic and Vascular Surgery, GB Pant Hospital [GIPMER], New Delhi, India.
Virmani S; Department of Cardiac Anaesthesia and Cardiothoracic and Vascular Surgery, GB Pant Hospital [GIPMER], New Delhi, India.
Minhas HS; Department of Cardiac Anaesthesia and Cardiothoracic and Vascular Surgery, GB Pant Hospital [GIPMER], New Delhi, India.
Malik S; Department of Cardiac Anaesthesia and Cardiothoracic and Vascular Surgery, GB Pant Hospital [GIPMER], New Delhi, India.
Pokaż więcej
Źródło :
Journal of cardiac surgery [J Card Surg] 2021 Oct; Vol. 36 (10), pp. 3749-3760. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Vasoplegia*/drug therapy
Vasoplegia*/etiology
Adult ; Cardiopulmonary Bypass/adverse effects ; Drug Therapy, Combination ; Humans ; Hydroxocobalamin/therapeutic use ; Leprostatic Agents/therapeutic use
Czasopismo naukowe
Tytuł :
Comparable HIV suppression by pegylated-IFN-α2a or pegylated-IFN-α2b during a 4-week analytical treatment interruption.
Autorzy :
Papasavvas E; The Wistar Institute, Philadelphia.
Azzoni L; The Wistar Institute, Philadelphia.
Ross BN; The Wistar Institute, Philadelphia.
Fair M; The Wistar Institute, Philadelphia.
Howell BJ; Merck, Inc., West Point.
Hazuda DJ; Merck, Inc., West Point.
Mounzer K; Jonathan Lax Immune Disorders Treatment Center, Philadelphia Field Initiating Group for HIV-1 Trials.
Kostman JR; John Bell Health Center, Philadelphia Field Initiating Group for HIV-1 Trials.
Tebas P; University of Pennsylvania, Department of Medicine, Philadelphia, Pennsylvania, USA.
Montaner LJ; The Wistar Institute, Philadelphia.
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2021 Oct 01; Vol. 35 (12), pp. 2051-2054.
Typ publikacji :
Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiviral Agents*/therapeutic use
HIV Infections*/drug therapy
Clinical Studies as Topic ; Drug Therapy, Combination ; Humans ; Interferon alpha-2/therapeutic use ; Polyethylene Glycols/therapeutic use ; Recombinant Proteins ; Treatment Outcome
Raport
Tytuł :
Peg-interferon alpha add-on Tenofovir disoproxil fumarate achieved more HBsAg loss in HBeAg-positive chronic hepatitis B naïve patients.
Autorzy :
Li J; Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qu L; Department of Infectious Diseases, East Hospital, Tongji University, Shanghai, China.
Sun X; Liver Disease Department, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Liu Y; Department of Infectious Diseases, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gong Q; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yu D; Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhang D; Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jiang J; Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Chen J; Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wei D; Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Han Y; Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Gao Y; Liver Disease Department, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zhang Q; Department of Infectious Diseases, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
She W; Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai, China.
Chen L; Department of Hepatic Diseases, Shanghai Public Health Clinical Center, Shanghai, China.
Zhang J; Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
Zhang X; Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Sino-French Research Centre for Life Sciences and Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło :
Journal of viral hepatitis [J Viral Hepat] 2021 Oct; Vol. 28 (10), pp. 1381-1391. Date of Electronic Publication: 2021 Jul 14.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Hepatitis B Surface Antigens*
Hepatitis B, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; DNA, Viral ; Drug Therapy, Combination ; Hepatitis B e Antigens ; Hepatitis B virus/genetics ; Humans ; Interferon-alpha/therapeutic use ; Polyethylene Glycols/therapeutic use ; Prospective Studies ; Tenofovir/therapeutic use ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies